Staphylococcus aureus (S. aureus) is a major human pathogen with several virulence factors. An 11-Year period Retrospective Pilot Study led by Saffiatou Darboe showed that PVL-SA strains accounted for 61.4% (180/293) of S. aureus isolates. PVL prevalence was high in both Gambian bacteraemia and SSTIs S. aureus strains. Antimicrobial resistance was low and included chloramphenicol (4.8%), cefoxitin (2.4%), ciprofloxacin (3.8%), erythromycin (8.9%), gentamicin (5.5%) penicillin (92.5%), tetracycline (41.0%), and sulfamethoxazole-trimethoprim (24.2%). There was no association of PVL with antimicrobial resistance.
A retrospective analysis was performed to investigate the prevalence of one such virulence factor (PVL) amongst clinical S. aureus samples. We found a high prevalence in our setting but antimicrobial resistance including methicillin resistance was low.
The report has been published in the Frontiers Media Journal
https://www.frontiersin.org/articles/10.3389/fcimb.2019.00170/full?&utm…
Congratulations to Saffie and team.
If you enjoyed this article and would like to build a career in global health, we offer a range of MSc programmes covering health and data, infectious and tropical diseases, population health, and public health and policy.
Available on campus or online, including flexible study that works around your work and home life, be part of a global community at the UK's no.1 public health university.